(HealthDay)—For patients undergoing lung transplantation (LTx), prophylactic azithromycin is associated with reduced risk of chronic lung allograft dysfunction (CLAD), according to a study ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Azithromycin significantly reduced the frequency of exacerbations (1.48 vs. 1.83 per patient-year, P<0.01), and increased the median time to first exacerbation (266 days vs. 174 days, P<0.001).

For patients undergoing lung transplantation (LTx), prophylactic azithromycin is associated with reduced risk of chronic lung allograft dysfunction (CLAD).

David Juurlink’s timely and otherwise thorough review of chloroquine, hydroxychloroquine and azithromycin1 omitted an important safety consideration for azithromycin that is relevant to recipients of ...

The women who received azithromycin were significantly less likely to experience a composite of endometritis, wound infection, or other infections within 6 weeks of delivery than women receiving ...

TOPLINE: Prophylactic azithromycin had no significant effect on survival without the development of chronic lung disease (CLD) in high-risk premature infants compared with placebo.

Find out what you need to know about prophylactic antibiotics. Discover the pros, cons, risks, and benefits, and how they may affect health.